Paragon 28 to Present at Upcoming Investor Conferences
March 01 2023 - 4:05PM
Business Wire
Paragon 28, Inc. (NYSE: FNA), a leading medical device company
exclusively focused on the foot and ankle orthopedic market, today
announced that Albert DaCosta, Chairman and CEO, and Steve Deitsch,
CFO, will be presenting in fireside chats at two upcoming investor
conferences. Paragon 28 will participate in the CG 2023
Musculoskeletal Conference on March 7th, 2023, and the 22nd Annual
Needham Virtual Healthcare Conference on April 19th, 2023.
Event: CG 2023 Musculoskeletal Conference Date: Tuesday, March
7, 2023 Time: 4:00pm ET / 1:00pm PT
Event: 22nd Annual Needham Virtual Healthcare Conference Date:
Wednesday, April 19, 2023 Time: 11:00am ET / 8:00am PT
Live and archived webcasts of the fireside chats will be
available on the “Investors” section of the Company’s website at
ir.paragon28.com.
About Paragon 28, Inc.
Based in Englewood, Colo., Paragon 28 is a leading medical
device company exclusively focused on the foot and ankle orthopedic
market and is dedicated to improving patient lives. From the onset,
Paragon 28® has provided innovative orthopedic solutions,
procedural approaches and instrumentation that cover a wide range
of foot and ankle ailments including fracture fixation, forefoot,
ankle, progressive collapsing foot deformity (PCFD) or flatfoot,
charcot foot and orthobiologics. The company designs products with
both the patient and surgeon in mind, with the goal of improving
outcomes, reducing ailment recurrence and complication rates, and
making the procedures simpler, consistent, and reproducible.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230301006006/en/
Investor Contact Matthew Brinckman Senior Vice President,
Strategy and Investor Relations Phone: (741) 336-0435
mbrinckman@paragon28.com
Paragon 28 (NYSE:FNA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Paragon 28 (NYSE:FNA)
Historical Stock Chart
From Aug 2023 to Aug 2024